Moreover, estrogens have been shown to activate the mechanistic target of rapamycin (mTOR) and phosphatidylinositol 3-kinase (PI3K) pathways [40, 41], and recent research has suggested that these pathways may play a role in the development and progression of sarcoidosis [42, 43]. This evidence concerns the gene MTOR and sarcoidosis.